| |
N=263 |
HR* (95% CI) |
p value |
| Cervical cytology |
|
|
|
| Negative |
136 |
1.000 |
|
| AGC |
64 |
2.648 (1.044-6.715) |
0.040 |
| AC |
63 |
5.280 (2.295-12.150) |
<0.001 |
| Age |
|
|
|
| <50 years |
46 |
1.000 |
|
| ≧50 years |
217 |
7.400 (1.014-54.016) |
0.048 |
| Stage |
|
|
|
| I, II |
216 |
1.000 |
|
| III, IV |
47 |
12.689 (6.330-25.437) |
<0.001 |
| Histological type |
|
|
|
| Endometrioid |
245 |
1.000 |
|
| Others |
18 |
9.375 (4.732-18.571) |
<0.001 |
| (containing serous) |
|
|
|
| Grade |
|
|
|
| G1,2 |
201 |
1.000 |
|
| G3 |
44 |
3.336 (1.443-7.712) |
0.026 |
| Myometrial invasion |
|
|
|
| ＜ 50% |
177 |
1.000 |
|
| ≧ 50% |
86 |
9.397 (4.115-21.459) |
<0.001 |
| Cervical involvement |
|
|
|
| Negative |
218 |
1.000 |
|
| Positive |
45 |
4.707 (2.435-9.100) |
<0.001 |
| Lymph node metastasis |
|
|
|
| Negative |
230 |
1.000 |
|
| Positive |
27 |
16.880 (8.327-34.216) |
<0.001 |
| Peritoneal cytology |
|
|
|
| Negative |
247 |
1.000 |
|
| Positive |
16 |
2.168 (0.767-6.133) |
N.S† |
| * Hazard Ratio † not significant |
|
|
|
|
